文献速递痛风与晶体性关节病

肌肉骨骼超声对痛风起始降尿酸治疗者受累关节痛风发作的预测价值:前瞻性队列研究

The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapy.
PubMed 文献 · Semin Arthritis Rheum · 2024-02-18

这项单中心前瞻性队列研究纳入至少有一次第一跖趾关节、踝或膝关节痛风发作且起始降尿酸治疗的痛风患者,基线与12个月随访时对受累关节行超声检查。结果显示,痛风石、双轨征和聚集体的超声评分与同一关节频繁(≥2次)痛风发作相关,痛风石评分高者风险最高。

要点

  • 第一跖趾关节痛风石超声阳性者频繁发作比例85.0% vs 46.0%(P<0.001)。
  • 第一跖趾关节痛风石评分每增加1分,频繁发作的比值比(OR)分别为5.19、7.91和13.79。
  • 踝关节痛风石评分为3分时预测频繁发作的OR=9.24(95%CI 2.85-29.91)。

核心结论

  • 基线超声显示的尿酸钠晶体沉积特征可预测起始降尿酸治疗后同一关节的频繁痛风发作,痛风石评分高者风险最高。

研究设计与样本

  • 单中心前瞻性队列研究,纳入至少有一次第一跖趾关节、踝或膝关节痛风发作的痛风患者,基线时行受累关节超声检查并起始降尿酸治疗,随访12个月。

主要发现

  • 第一跖趾关节痛风石阳性者频繁发作比例85.0% vs 46.0%(P<0.001),聚集体阳性者78.8% vs 59.0%(P<0.01)。
  • 踝关节痛风石阳性者频繁发作比例54.6% vs 20.8%(P<0.001),聚集体阳性者60.0% vs 35.9%(P<0.05)。
  • 膝关节痛风石阳性者频繁发作比例68.4% vs 28.6%(P<0.05)。
  • 第一跖趾关节痛风石评分每增加1分,频繁发作的OR分别为5.19(95%CI 1.26-21.41)、7.91(95%CI 2.23-28.14)和13.79(95%CI 3.79-50.20)。
  • 踝关节痛风石评分为3分时预测频繁发作的OR=9.24(95%CI 2.85-29.91)。

关键数值与推荐

  • 采用OMERACT评分(痛风石、双轨征、聚集体)分析超声评分与12个月内同一关节频繁(≥2次)痛风发作的关系。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate whether ultrasound findings of monosodium urate (MSU) crystal deposition predict frequent gout flares in index joints over 12 months. METHODS: This single-center study enrolled people with at least one gout flare involving the MTP1, ankle or knee joint. The most painful or most frequently joint was identified as index joint for analysis. All participants were started on urate-lowering therapy and had an ultrasound scan of the index joints at the baseline visit. OMERACT scores (for tophus, double contour sign and aggregates) were used to analyze whether ultrasound scores predicted frequent (≥2) gout flares in the index joint over 12 months. RESULTS: Frequent flares were significantly higher in those with ultrasound findings in all index joints (MTP1: tophus: 85.0% vs 46.0%, P < 0.001, aggregates: 78.8% vs 59.0%, P < 0.01; ankle: tophus: 54.6% vs 20.8%, P < 0.001; aggregates: 60.0% vs 35.9%, P < 0.05; knee: tophus: 68.4% vs 28.6%, P < 0.05). For the MTP1, for each 1-point increase in tophus score, the odds of frequent gout flares increased by 5.19 [(95%CI: 1.26-21.41), 7.91 [(95%CI: 2.23-28.14), and 13.79 [(95%CI: 3.79-50.20)] fold respectively. For the ankle, a tophus score of 3 markedly improved the prediction of the frequent flares [OR= 9.24 (95%CI=2.85-29.91)]. Semi-quantitative sum scores were associated with frequent flares with an OR (95%CI) of 13.66 (3.44-54.18), P < 0.001 at the MTP1, 7.05 (1.98-25.12), P < 0.001 at the ankle. CONCLUSION: Ultrasound features of MSU crystal deposition at the MTP1 and knee predict subsequent risk of frequent gout flares in the same joints following initiation of urate-lowering therapy, with the highest risk in those with high tophus scores.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Han L, Li R, Dalbeth N, et al. The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapy. Semin Arthritis Rheum. 2024. PMID: 38422901. doi:10.1016/j.semarthrit.2024.152418

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。